Technical Note: A Counting Strategy for Estimating Plasma Cell Number in CD138-Stained Bone Marrow Core Biopsy Sections

Size: px
Start display at page:

Download "Technical Note: A Counting Strategy for Estimating Plasma Cell Number in CD138-Stained Bone Marrow Core Biopsy Sections"

Transcription

1 Available online at Technical Note: A Counting Strategy for Estimating Plasma Cell Number in CD138-Stained Bone Marrow Core Biopsy Sections Fred B. Smith and Ashraf Elnawawi Department of Pathology, Saint Vincent s Catholic Medical Centers of New York Manhattan, New York, and Department of Pathology, New York Medical College, Valhalla, New York Abstract. Plasma cells are readily identified microscopically after immunostaining for the CD138 antigen, and CD138-stained bone marrow core biopsy sections have proved superior to Giemsa-stained aspirate smears and hematoxylin-eosin (H&E) sections for determining plasma cell percentages in marrow. The CD138-stained plasma cell percentage is generally obtained by visual estimation, after viewing the entire section. We propose an alternative method, in which the microscopist initially views the immunostained section under low- and medium-power magnification, then selects a single high-power field in which the relative concentration of plasma cells appears most representative of the section as a whole, and performs a manual differential count of plasma cells in that field. On 44 CD138-stained core biopsy specimens from patients with plasma cell myeloma, selected area counting provided plasma cell percentage values that were more closely correlated with total section plasma cell area, determined by computerized image cytometry, than were visual estimates. This simple method requires only slightly more time than visual appraisal, does not require extensive training or experience, and appears to provide a more accurate estimate of the plasma cell population within the entire specimen. Keywords: plasma cell, plasma cell myeloma, immunohistochemistry, CD138 antigen Introduction Address correspondence to Fred B. Smith, M.D., Dept. of Pathology, St. Vincent s Catholic Medical Centers of New York, 170 West 12 Street, New York, NY 10011, USA; tel ; fax ; fsmith@svcmcny.org. The relative number of plasma cells in a bone marrow specimen is a clinical parameter important in the diagnosis and management of plasma cell dyscrasia [1]. The plasma cell number, expressed as a percentage of total marrow hematopoietic cells, has traditionally been obtained by manual differential counting of Giemsa-stained marrow aspirate smears (smear counts) or by estimation from H&E-stained core biopsy sections. CD138 antigen is expressed by neoplastic and nonneoplastic plasma cells, but not by other cells normally present in bone marrow, and the recent introduction into clinical practice of immunostaining for CD138 has greatly facilitated the recognition and quantitation of marrow plasma cells [2,3]. Estimated plasma cell percentages based on visual microscopic appraisal of entire CD138- stained marrow core biopsy sections (CD138 overview estimates) have been reported to show greater inter-observer reproducibility than those based on smear counts or H&E-section estimates, and to correlate well with plasma cell percentages obtained by image cytometry [4]. CD138 overview estimates presumably achieve these superior results because the immunostaining, unlike traditional methods, makes it possible to recognize plasma cells under low-magnification microscopy, when their numbers can be better judged in relation to other cells of the marrow. Although CD138 estimates have thus improved diagnostic accuracy, they must be assumed to be subject to particular sources of error generated by /08/ $ by the Association of Clinical Scientists, Inc.

2 Plasma cell estimation in core biopsy of bone marrow 139 visual overviews. Because plasma cells are larger than the majority of hematopoietic cells, one would expect the observer to be influenced by the relatively larger aggregate stained area of the plasma cells and therefore to tend systematically to overestimate their number. In addition, there is a risk that the accuracy of the estimate could be influenced by the distribution pattern of the plasma cells within the marrow, since this is known to vary widely among patients [5]. Perceptual psychologists have noted that when observers visually estimate the numbers of objects too numerous to count (numerosity estimates), they tend to underestimate numbers if the objects are clustered and to overestimate numbers if the objects are dispersed uniformly against the background [6,7]. One would expect the effect of this error to be magnified in plasma cell estimates by overview, since the percentage is derived as a ratio of two numerosity estimates, that of the total marrow cell population and of the stained plasma cells. In carrying out this study, we asked whether we could improve on the visual overview approach to CD138 plasma cell estimates by including a high-magnification manual counting step in the assessment, using the initial low-magnification overview only to select the counting area, and not attempting to estimate cell numbers on the overview. Assessment of CD138-stained core biopsy sections by selected area counting would thus closely parallel the steps used in performing smear counts. We retrospectively assessed CD138- stained bone marrow core biopsies from our departmental archives in this manner, and compared the results to those obtained previously by overview estimates and to those obtained by computerized image cytometry. Materials and Methods Case material. Archived histologic sections from bone marrow core biopsies on patients with plasma cell myeloma, which were performed in 2006 and stained previously for demonstration of CD138 antigen, were retrieved for review. Forty-four sections were judged technically adequate for purposes of the study (ie, marrow area >1 mm 2, cellularity >10%). The patient group from whom the biopsies had been obtained comprised 25 males and 19 females, and their mean age was 60.9 yr (SD ±10.7 yr). Serum total protein values ranged from 4.0 to 8.7 g/dl, and 28 patients had a detectable serum M-protein (11 IgG-κ, 5 IgA-κ, 4 IgG-λ, 2 IgA-λ, 6 other types), at concentrations of 0.08 to 2.16 g/dl. Twentytwo of the patients had detectable free light chains in the urine (23.9 to mg/l). Plasma cell estimates by visual overview and by smear counts were obtained from the surgical pathology reports on the biopsies. Overview estimates were listed on 42 of the pathology reports and smear counts on 32. The procedure for de-identification of the sections and reports, as well as the protocol for the entire study, was approved by the St. Vincent s Catholic Medical Centers of New York Integrated Scientific and Ethical Review Board. Plasma cell estimation by selected area counting. The sections were initially scanned at low (100x) and intermediate (200x) magnification to assess the distribution and concentration of the darkly stained plasma cells. An area within the section was then selected that was judged to have approximately the same concentration of plasma cells as the section as a whole. At high magnification (400x), a region containing approximately 200 cells was selected for counting, and delimited by use of the field diaphragm on the microscope light source. Plasma cells and other nucleated cells in the delimited region were counted with a manual cell counter, and the result was computed as plasma cell percentage. The method of field selection is illustrated in Fig. 1. Image cytometry. The sections were analyzed with a CAS 200 Image Analysis System, using Quantitative Nuclear Antigen software and 400x magnification. Digital images of all portions of the biopsy sections containing hematopoietic tissue were analyzed, with the nuclear threshold setting lowered so that both cytoplasm and nuclei of hematopoietic cells were included in the nuclear image. The antibody threshold was set so that only stained plasma cells were included in the antibody image, and the computed percent area score thus represented the aggregate area of plasma cells, as a percent of the total hematopoietic cell area, within the section. This method was previously used for quantitation of stained cells within a mixed tissue cell population [8]. Data analysis. Results from image cytometry and selected area counting were recorded in an MS Excel file, along with the corresponding overview estimates and smear counts from the pathology reports, and pairwise comparisons of methods were made with StatistXL software, using simple correlation and computations of Pearson s r and Student s t. Results Descriptive statistics for the plasma cell percentages obtained in the study cases by each of the methods (selected area counting, image cytometry, overview estimate, and smear count) are shown in Table 1. The mean of the aspirate smear counts was appreciably lower than the means obtained by the other methods; this may reflect the plasma cell stripping artifact in aspirate smears [3].

3 140 Table 1. Plasma cell percentage of the study cases, assessed by four methods. CD138 section overview Smear count Selected area count Image cytometry % area number mean ± SD 19.2 ± ± ± ± 10.7 range Fig. 1. Area selection for counting of CD138-positive plasma cells. Left, encircled area selected at intermediate-power magnification (200x) to contain concentration of plasma cells representative of section as a whole. Right, selected area at highpower magnification (400x), delimited using microscope field diaphragm. This area was found to contain 196 nucleated cells, 25 of which (13%) were plasma cells. Fig. 2. Correlation of plasma cell percentages by CD138 section overview, Giemsa-stained smear count, and CD138 section selected area count with plasma cell percent area (PA) score obtained by image cytometry.

4 Plasma cell estimation in core biopsy of bone marrow 141 Correlations between each of the manual method results with those obtained by image cytometry are shown in Fig. 2. Selected area counts were more highly correlated with the image cytometry measurements than were the smear counts or overview estimates. Although smear count percentages were lower than those obtained by overview estimates, they showed better correlation with image cytometry. Discussion In this study, selected area counts better approximated plasma cell numbers on CD138- stained bone marrow core biopsy sections than did visual overview estimates, with image cytometry measurements of plasma cell area as a gold standard for comparison. We believe this reflects, at least in part, a decreased impact of numerosity-related error in arriving at the final estimate of plasma cell percentage by the selected area count method. Although the area selection step is subjective and susceptible to observer bias, the counting step in the procedure is not. In overview estimation, however, the entire procedure is based on a subjective judgment. Smear counts in our study also outperformed overview estimates, based on image cytometry correlation, although they systematically undercounted plasma cells. This probably reflects both the partial objectivity of the method (only selection of the area of the smear for counting is subjective) and the under-representation of plasma cells in marrow aspirate samples, as previously noted [3]. It seems likely that the accuracy of CD138 overview estimates could be substantially increased by training the individuals who perform the estimates. Observers could initially examine a training set of marrow sections calibrated by image cytometry and then be provided with feedback on their estimates. In performing a similar visual estimation task, assessment of land areas from aerial overviews, observers dramatically improved their estimates when trained by feedback from image analysis [9]. In a study by Al-Quran et al [4], the reported CD138 overview estimates of plasma cells were performed by 2 individuals identified as expert hematopathologists, who may also have been experienced in image cytometry. We suspect that training effects may explain the much better correlation between overview estimates and image cytometry they reported, compared to our results. The overview estimates in our study were obtained from pathology reports and were provided by 4 general surgical pathologists, none of whom had previously performed image cytometry on marrow specimens. We believe that their estimates represent what would be expected from any conscientious microscopist not specifically trained for the task or aware of numerosity-related illusions. Judging from our experience, selected area counting appears to be a better means of assessing plasma cell numbers in CD138-stained marrow core biopsy sections of myeloma patients than overview estimation in the usual laboratory setting. We caution that our findings have not been tested in non-myeloma patients, and therefore may not pertain to normal patients or those with reactive plasmacytosis. We note, however, that the group of myeloma patients we studied included a subset in disease remission, with plasma cell numbers in the normal and reactive range. Until this issue has been explored more fully, we suggest that laboratories performing estimates of plasma cell numbers in bone marrow biopsies stained for CD138 antigen should not expect overview estimates to closely approximate the actual cell numbers, unless the individuals performing the estimates have been specially trained for this task. Performance of a selected area count on a CD138 section requires no special training and takes less time than a traditional smear count, and the results are not subject to the undercount bias inherent in assessing aspirate smears. References 1. Ravikumar SV, Fonseca R, Dispenzieri A, Lacy MQ, Lust JA, Witzig TE, Therneau TM, Kyle RA, Greipp PR, Gertz MA. Methods for estimation of bone marrow plasma cell involvement in myeloma: predictive value for response and survival in patients undergoing autologous stem cell transplantation. Am J Hematol 2001;68: Chilosi M, Adami F, Lestani M, Montagna L, Cimarosto L, Semanzato G, Pizzolo G, Menestrina F. CD138/ syndecan-1: a useful immunohistochemical marker of

5 142 normal and neoplastic plasma cells on routine trephine bone marrow biopsies. Mod Pathol 1999;12: Dunphy CH, Nies MK, Gabriel DA. Correlation of plasma cell percentages by CD138 immunohistochemistry, cyclin D1 status, and CD56 expression with clinical parameters and overall survival in plasma cell myeloma. Appl Immunohistochem Mol Morphol 2007; 15: Al-Quran SZ, Yang L, Magill JM, Braylan RC, Douglas- Nikitin VK. Assessment of bone marrow plasma cell infiltrates in multiple myeloma: the added value of CD138 immunohistochemistry. Human Pathol 2007; 38: Bartl R, Frisch B, Fateh-Moghadam A, Kettner G, Jaeger K, Sommerfeld W. Histologic classification and staging of multiple myeloma. A retrospective and prospective study of 674 cases. Am J Clin Pathol 1987;87: Ginsburg N. Numerosity estimation as a function of stimulus organization. Perception 1991;20: Cousins JB, Ginsburg N. Subject correlation and the regular-random numerosity illusion. J Gen Psychol 1983;108: Smith FB, Arias JH, Elmquist TH, Mazzara JT. Microvascular cytomegalovirus endothelialitis of the lung. A possible cause of secondary pulmonary hypertension in a patient with AIDS. Chest 1998;114: Gallegos A. Design and evaluation of a computer aided calibration program for visual estimation of vegetation cover. Sveriges Landtbruksuniversitet Arbetsrapport , accessed 10/5/2007 at se/resana/nils/publikationer/arb_rapp_142.pdf.

The diagnosis and classification of plasma cell dyscrasias

The diagnosis and classification of plasma cell dyscrasias Quantitation of Plasma Cells in Bone Marrow Aspirates by Flow Cytometric Analysis Compared With Morphologic Assessment Kristi J. Smock, MD; Sherrie L. Perkins, MD, PhD; David W. Bahler, MD, PhD Context.

More information

Guidelines for the diagnosis of Multiple Myeloma Ass.lec.: Dr. Karam T. Agha M.Sc.Pathology

Guidelines for the diagnosis of Multiple Myeloma Ass.lec.: Dr. Karam T. Agha M.Sc.Pathology Guidelines for the diagnosis of Multiple Myeloma 2014 By:British Committee for Standards in Haematology (BCSH) Ass.lec.: Dr. Karam T. Agha M.Sc.Pathology Diagnosis, prognostic factors and disease monitoring

More information

Uniform Labeling of Blocks and Slides in Surgical Pathology

Uniform Labeling of Blocks and Slides in Surgical Pathology Uniform Labeling of Blocks and Slides in Surgical Pathology Guideline from the College of American Pathologists and the National Society for Histotechnology Published : Archives of Pathology and Laboratory

More information

Clinical Course and Prognosis of Smoldering (Asymptomatic) Multiple Myeloma

Clinical Course and Prognosis of Smoldering (Asymptomatic) Multiple Myeloma T h e n e w e ng l a nd j o u r na l o f m e dic i n e original article Clinical Course and Prognosis of Smoldering (Asymptomatic) Multiple Myeloma Robert A. Kyle, M.D., Ellen D. Remstein, M.D., Terry

More information

Single Tube, Six-Color Flow Cytometric Analysis Is a Sensitive and Cost-Effective Technique for Assaying Clonal Plasma Cells

Single Tube, Six-Color Flow Cytometric Analysis Is a Sensitive and Cost-Effective Technique for Assaying Clonal Plasma Cells Hematopathology / Flow Cytometric Analysis of Clonal Plasma Cells Single Tube, Six-Color Flow Cytometric Analysis Is a Sensitive and Cost-Effective Technique for Assaying Clonal Plasma Cells Derek K. Marsee,

More information

June Laboratory Evaluation of Plasma Cell Neoplasms Stan McCormick, MD

June Laboratory Evaluation of Plasma Cell Neoplasms Stan McCormick, MD June 2011 Laboratory Evaluation of Plasma Cell Neoplasms Stan McCormick, MD In this issue we review the laboratory work up of patients suspected of having a plasma cell neoplasm. As the range in clinical

More information

Comparing the Quality of Fixation for Gel-based Formalin (Formagel) versus Traditional Liquid-Based Formalin for Immunohistochemistry

Comparing the Quality of Fixation for Gel-based Formalin (Formagel) versus Traditional Liquid-Based Formalin for Immunohistochemistry Comparing the Quality of Fixation for Gel-based Formalin (Formagel) versus Traditional Liquid-Based Formalin for Immunohistochemistry Brian H. Le, M.D., Reading Hospital Reviewed by Michael R. LaFrinere,

More information

Assessment of Serum Free Light Chain Assays for Plasma Cell Disorder Screening in a Veterans Affairs Population

Assessment of Serum Free Light Chain Assays for Plasma Cell Disorder Screening in a Veterans Affairs Population Available online at www.annclinlabsci.org Annals of Clinical & Laboratory Science, vol 36, no. 2, 2006 157 Assessment of Serum Free Light Chain Assays for Plasma Cell Disorder Screening in a Veterans Affairs

More information

Freelite for Measurement of Urine-Free Light Chains in Monoclonal Gammopathies

Freelite for Measurement of Urine-Free Light Chains in Monoclonal Gammopathies Freelite for Measurement of Urine-Free Light Chains in Monoclonal Gammopathies Montgomery Lobe, MD, and Donald Pasquale, MD Abstract Monoclonal gammopathies are characterized by production of monoclonal

More information

Stem Cells and Multiple Myeloma

Stem Cells and Multiple Myeloma Stem Cells and Multiple Myeloma What is Multiple Myeloma Multiple Myeloma is a cancer of your plasma cells, a type of white blood cell present in your bone marrow Plasma cells normally make proteins called

More information

بسم اهلل الرمحن الرحيم

بسم اهلل الرمحن الرحيم بسم اهلل الرمحن الرحيم Definition Multiple myeloma is a neoplastic plasma cell dyscrasia (PCD) that generally produced a monoclonal immunoglobulin protein, characterized by a clinical pentad: (a) anemia;

More information

TheraLin. Universal Tissue Fixative Enabling Molecular Pathology

TheraLin. Universal Tissue Fixative Enabling Molecular Pathology TheraLin Universal Tissue Fixative Enabling Molecular Pathology TheraLin Universal Tissue Fixative Enabling Molecular Pathology Contents Page # TheraLin Universal Tissue Fixative 3 Introduction 5 Easy

More information

The histopathology of myeloma in the bone marrow

The histopathology of myeloma in the bone marrow Journal of clinical and experimental hematopathology Vol. 58 No.2, 61-67, 2018 JC lin EH xp ematopathol Review Article The histopathology of myeloma in the bone marrow Masahiko Fujino Myeloma is characterized

More information

CAP Accreditation Checklists 2016 Edition

CAP Accreditation Checklists 2016 Edition CAP Accreditation Checklists 2016 Edition The College of American Pathologists (CAP) accreditation checklists contain the CAP accreditation program requirements, developed on more than 50 years of insight

More information

Image Analysis. Tools for basic and translational research. visualize analyze interpret report archive customize

Image Analysis. Tools for basic and translational research. visualize analyze interpret report archive customize Image Analysis Tools for basic and translational research visualize analyze interpret report archive customize Unlock the benefits of image analysis. Image analysis is an integrated part of Aperio s digital

More information

Histology Pattern Recognition Software in Investigative Pathology

Histology Pattern Recognition Software in Investigative Pathology Histology Pattern Recognition Software in Investigative Pathology J. Webster, DVM, PhD, DACVP Laboratory of Cancer Biology and Genetics National Cancer Institute, Bethesda, MD Pathology Visions 2011 November

More information

BIMM18 Dec 20 th - Flow cytometry in clinical diagnostics

BIMM18 Dec 20 th - Flow cytometry in clinical diagnostics BIMM18 Dec 20 th - Flow cytometry in clinical diagnostics I. B cell leukemia and lymphomas Immunophenotyping as part of the diagnostic work- up of hematologic malignancies offers a rapid and effective

More information

Case Report Serum Free Light Chain Only Myeloma with Cytoplasmic IgM

Case Report Serum Free Light Chain Only Myeloma with Cytoplasmic IgM Hindawi Publishing Corporation Case Reports in Hematology Volume 2014, Article ID 676913, 5 pages http://dx.doi.org/10.1155/2014/676913 Case Report Serum Free Light Chain Only Myeloma with Cytoplasmic

More information

Histocompatibility. Revised and effective July 14, Histocompatibility Standard 1 (HC S1)

Histocompatibility. Revised and effective July 14, Histocompatibility Standard 1 (HC S1) Clinical Laboratory s of Practice The following specialty sustaining standards of practices shall be incorporated into the laboratory s quality management system, where applicable to the scope of services

More information

CASE REPORT AND REVIEW OF THE LITERATURE

CASE REPORT AND REVIEW OF THE LITERATURE Page 76 / SA ORTHOPAEDIC JOURNAL Summer 2009 C ASE R EPORT AND R EVIEW OF THE L ITERATURE Low-secretory multiple myeloma HF Visser MBChB(Pret) Senior Registrar, Department Orthopaedic Surgery, University

More information

Laboratory Persistence and Clinical Progression of Small Monoclonal Abnormalities

Laboratory Persistence and Clinical Progression of Small Monoclonal Abnormalities Immunopathology / Persistence of IFE MGUS Laboratory Persistence and Clinical Progression of Small Monoclonal Abnormalities David L. Murray, MD, PhD, 1 Justin L. Seningen, MD, 1 Angela Dispenzieri, MD,

More information

ADAPTIVE BIOTECHNOLOGIES DIAGNOSTIC PORTAL: ACCOUNT LOGIN

ADAPTIVE BIOTECHNOLOGIES DIAGNOSTIC PORTAL: ACCOUNT LOGIN ACCOUNT LOGIN 1. Create an account. To set up your account for our online order entry and reporting system, please go to: https://diagnostics.adaptivebiotech.com/account/login. After signing up, please

More information

STTARR Image Analysis Core Facility UHN Pathology Validation Core

STTARR Image Analysis Core Facility UHN Pathology Validation Core STTARR Image Analysis Core Facility UHN Pathology Validation Core Quantitative Tools for Pathology Research OMPRN Pathology Matters Conference, October 2017 www.sttarr.com STTARR Image Analysis Core Facility

More information

SWOG ONCOLOGY RESEARCH PROFESSIONAL (ORP) MANUAL GENERAL FORMS AND GUIDELINES MYELOMA FORMS CHAPTER 16D REVISED: SEPTEMBER 2016

SWOG ONCOLOGY RESEARCH PROFESSIONAL (ORP) MANUAL GENERAL FORMS AND GUIDELINES MYELOMA FORMS CHAPTER 16D REVISED: SEPTEMBER 2016 MYELOMA FORMS The guidelines and figures below are specific to Myeloma studies. The information in this manual does NOT represent a complete set of required forms for any myeloma study. Please refer to

More information

CAP Accreditation Checklists 2017 Edition

CAP Accreditation Checklists 2017 Edition CAP Accreditation Checklists 2017 Edition The College of American Pathologists (CAP) accreditation checklists contain the CAP accreditation program requirements, developed on more than 50 years of insight

More information

COPYRIGHTED MATERIAL. Tissue Preparation and Microscopy. General Concepts. Chemical Fixation CHAPTER 1

COPYRIGHTED MATERIAL. Tissue Preparation and Microscopy. General Concepts. Chemical Fixation CHAPTER 1 CHAPTER 1 Tissue Preparation and Microscopy General Concepts I. Biological tissues must undergo a series of treatments to be observed with light and electron microscopes. The process begins by stabilization

More information

Serum Free Light Chain (FLC) Measurement Can Aid Capillary Zone Electrophoresis in Detecting Subtle FLC-Producing M Proteins

Serum Free Light Chain (FLC) Measurement Can Aid Capillary Zone Electrophoresis in Detecting Subtle FLC-Producing M Proteins Immunopathology / DETECTING SUBTLE FLC-PRODUCING M PROTEINS Serum Free Light Chain (FLC) Measurement Can Aid Capillary Zone Electrophoresis in Detecting Subtle FLC-Producing M Proteins Nasir A, Bakshi,

More information

A novel assessment of the quality of immunohistostaining overcomes the limitations of current methods

A novel assessment of the quality of immunohistostaining overcomes the limitations of current methods ARTICLE IN PRESS Pathology Research and Practice 204 (2008) 323 328 ORIGINAL ARTICLE A novel assessment of the quality of immunohistostaining overcomes the limitations of current methods Avi Eisenthal,

More information

2111: ALL Post-HCT. Add/ Remove/ Modify. Manual Section. Date. Description. Comprehensive Disease- Specific Manuals

2111: ALL Post-HCT. Add/ Remove/ Modify. Manual Section. Date. Description. Comprehensive Disease- Specific Manuals 2111: ALL Post-HCT The Acute Lymphoblastic Leukemia Post-HCT Data Form is one of the Comprehensive Report Forms. This form captures ALL-specific post-hct data such as: planned treatments post-hct, the

More information

Smoldering Multiple Myeloma

Smoldering Multiple Myeloma Smoldering Multiple Myeloma S. Vincent Rajkumar Professor of Medicine Mayo Clinic Scottsdale, Arizona Rochester, Minnesota Jacksonville, Florida Mayo Clinic College of Medicine Mayo Clinic Comprehensive

More information

Survey of Neural Networks in Digital Pathology and Pathology Workflow

Survey of Neural Networks in Digital Pathology and Pathology Workflow Survey of Neural Networks in Digital Pathology and Pathology Workflow Christianne Dinsmore 1 1 Department of Computing and Digital Media DePaul University Chicago, IL Abstract Digital pathology has already

More information

DIAGNOSIS OF MYELOMA BASED ON THE 2014 INTERNATIONAL MYELOMA WORKING GROUP

DIAGNOSIS OF MYELOMA BASED ON THE 2014 INTERNATIONAL MYELOMA WORKING GROUP INDONESIAN JOURNAL OF CLINICAL PATHOLOGY AND MEDICAL LABORATORY Majalah Patologi Klinik Indonesia dan Laboratorium Medik Page 196 2018 March; 24(2): 196-200 p-issn 0854-4263 e-issn 2477-4685 Available

More information

CME/SAM. Limited Flow Cytometry Panels on Bone Marrow Specimens Reduce Costs and Predict Negative Cytogenetics

CME/SAM. Limited Flow Cytometry Panels on Bone Marrow Specimens Reduce Costs and Predict Negative Cytogenetics Limited Flow Cytometry Panels on Bone Marrow Specimens Reduce Costs and Predict Negative Cytogenetics Douglas G. Hoffmann, MD, and Burton H. Kim, MD From the Department of Pathology, Wellstar Health System,

More information

BUILT TO CONCENTRATE. Magellan is an autologous concentration system that delivers concentrated platelets and cells at the point of care.

BUILT TO CONCENTRATE. Magellan is an autologous concentration system that delivers concentrated platelets and cells at the point of care. BUILT TO CONCENTRATE Magellan is an autologous concentration system that delivers concentrated platelets and cells at the point of care. DELIVER PERSONALIZED MEDICINE Every patient has a unique biology

More information

EDUCATIONAL COMMENTARY LABORATORY EVALUATION OF IMMUNOPROLIFERATIVE DISORDERS

EDUCATIONAL COMMENTARY LABORATORY EVALUATION OF IMMUNOPROLIFERATIVE DISORDERS Commentary provided by: Louann W. Lawrence, Dr.PH, MLS (ASCP) Professor Emeritus, Retired Louisiana State University Health Sciences Center New Orleans, LA EDUCATIONAL COMMENTARY LABORATORY EVALUATION

More information

Clinico hematological profile of multiple myeloma in tertiary care Hospital, Pune

Clinico hematological profile of multiple myeloma in tertiary care Hospital, Pune Original article Clinico hematological profile of multiple myeloma in tertiary care Hospital, Pune Dr. Sagale MS, Dr. Dangmali DP, Dr. Rane SR, Dr. Kulkarni KK, Dr. Puranik SC Department of Pathology,

More information

GenomeMe. GeneAb TM BRAF V600E. Clone: IHC600 Source: Mouse Monoclonal Positive Control: Colorectal Adenocarcinoma

GenomeMe. GeneAb TM BRAF V600E. Clone: IHC600 Source: Mouse Monoclonal Positive Control: Colorectal Adenocarcinoma GeneAb TM BRAF V600E Clone: IHC600 Source: Mouse Monoclonal Positive Control: Colorectal Adenocarcinoma 1. Intended Use This antibody is intended for in vitro diagnostic (IVD) use. The BRAF V600E (IHC600)

More information

NEW YORK STATE DEPARTMENT OF HEALTH CLINICAL LABORATORY EVALUATION PROGRAM. Crosswalk of adopted revisions to Cytopathology Standards

NEW YORK STATE DEPARTMENT OF HEALTH CLINICAL LABORATORY EVALUATION PROGRAM. Crosswalk of adopted revisions to Cytopathology Standards 1 (CY S1) If the primary specimen is cellular, or examination at the cellular level is requested, the laboratory must hold a valid permit in the category of cytopathology. Examination of nongynecologic

More information

SOP# version e1.0 Material Handling and Documentation TMA's from Paraffin Embedded Tissue Blocks

SOP# version e1.0 Material Handling and Documentation TMA's from Paraffin Embedded Tissue Blocks CTRNet Standard Operating Procedure SOP Number: 8.3.010 Version e1.0 Supersedes: SR 001.001 Effective Date 09 Jan 08 Subject: TMA's from Paraffin Embedded Tissue Blocks Category Material Handling and Documentation

More information

initial single-cell analysis, with a pragmatic focus on surface markers with the highest potential for

initial single-cell analysis, with a pragmatic focus on surface markers with the highest potential for Supplementary Figure 1: Summary of the exclusionary approach to surface marker selection for initial single-cell analysis, with a pragmatic focus on surface markers with the highest potential for protein

More information

What do you do, with an M protein?

What do you do, with an M protein? What do you do, with an M protein? Cancer Day for Primary Care Emily Rimmer MD FRCPC January 31, 2014 emily.rimmer@cancercare.mb.ca Disclosure of Potential for Conflict of Interest Name of presenter: Emily

More information

Urine Protein Electrophoresis and Immunoelectrophoresis Using Unconcentrated or Minimally Concentrated Urine Samples

Urine Protein Electrophoresis and Immunoelectrophoresis Using Unconcentrated or Minimally Concentrated Urine Samples Immunopathology / Electrophoresis of Unconcentrated Urine Samples Urine Protein Electrophoresis and Immunoelectrophoresis Using Unconcentrated or Minimally Concentrated Urine Samples Anja C. Roden, MD,

More information

PCCS Growth Media, Cell Tagging, Cell Separation Final Assignment. Igneris Rosado-Erazo. Panama College of Cell Science

PCCS Growth Media, Cell Tagging, Cell Separation Final Assignment. Igneris Rosado-Erazo. Panama College of Cell Science Running Head: Growth Media, Cell Tagging, Cell Separation PCCS Growth Media, Cell Tagging, Cell Separation Final Assignment Igneris Rosado-Erazo Panama College of Cell Science In partial fulfillment of

More information

LABORATORY ASSESSMENT OF HAEMATOLOGY ONCOLOGY IMMUNOPHENOTYPING. First Edition Australasian Cytometry Society Laboratory Assessment Document

LABORATORY ASSESSMENT OF HAEMATOLOGY ONCOLOGY IMMUNOPHENOTYPING. First Edition Australasian Cytometry Society Laboratory Assessment Document LABORATORY ASSESSMENT OF HAEMATOLOGY ONCOLOGY IMMUNOPHENOTYPING First Edition 2018 Australasian Cytometry Society Laboratory Assessment Document Paper-based publications This work is copyright. You may

More information

Integrated Radiology & Pathology Diagnostic Services: The Time is Now at UCLA

Integrated Radiology & Pathology Diagnostic Services: The Time is Now at UCLA Integrated Radiology & Pathology Diagnostic Services: The Time is Now at UCLA Scott W Binder MD Pritzker Professor of Clinical Pathology and Dermatology Senior Vice Chair Director, Pathology Clinical Services

More information

chronic leukemia lymphoma myeloma differentiated 14 September 1999 Pr e- Transformed Ig Su rf ace Su rf ace Secre ted Myelom a

chronic leukemia lymphoma myeloma differentiated 14 September 1999 Pr e- Transformed Ig Su rf ace Su rf ace Secre ted Myelom a Disease Usual phenotype acute leukemia precursor chronic leukemia lymphoma myeloma differentiated Pr e- B-ce ll B-ce ll Transformed B-ce ll Plasma cell Ig Su rf ace Su rf ace Secre ted Major malignant

More information

DIAGNOSE AND TREAT WITH ANTIBODIES THAT RECOGNIZE NATIVE HUMAN PROTEIN EPITOPES IN BLOOD AND TISSUE

DIAGNOSE AND TREAT WITH ANTIBODIES THAT RECOGNIZE NATIVE HUMAN PROTEIN EPITOPES IN BLOOD AND TISSUE DIAGNOSE AND TREAT WITH ANTIBODIES THAT RECOGNIZE NATIVE HUMAN PROTEIN EPITOPES IN BLOOD AND TISSUE EXECUTIVE SUMMARY Oncologists reviewing blood and tissue test results face the same problems: Is the

More information

PERFECT-COUNT MICROSPHERES

PERFECT-COUNT MICROSPHERES PERFECT-COUNT MICROSPHERES Perfect-Count Microspheres-Product code PCB-100 for 100 tests Introduction In recent years, the determination of absolute cell counts has been shown to be relevant in different

More information

Hevylite: New strategies for Diagnosis, Monitoring and Prognosis of monoclonal gammopathies

Hevylite: New strategies for Diagnosis, Monitoring and Prognosis of monoclonal gammopathies Hevylite: New strategies for Diagnosis, Monitoring and Prognosis of monoclonal gammopathies AR Bradwell. University of Birmingham and Binding Site Ltd How good are tests for monoclonal monoclonal proteins?

More information

Effective Health Care Program

Effective Health Care Program Comparative Effectiveness Review Number 73 Effective Health Care Program Serum Free Light Chain Analysis for the Diagnosis, Management, and Prognosis of Plasma Cell Dyscrasias Executive Summary Background

More information

Electron microscopy technology of reticulocytes after sorting with

Electron microscopy technology of reticulocytes after sorting with Electron microscopy technology of reticulocytes after sorting with magnetic beads The Cell Analysis Center Scientific Bulletin Part 2 For efficient analysis of cells, sorting of the target cells is crucial.

More information

Liquid. This product is shipped with dry ice. Upon receipt, store it immediately at the temperature recommended below.

Liquid. This product is shipped with dry ice. Upon receipt, store it immediately at the temperature recommended below. PRIME-XV MSC Expansion SFM PRIME-XV MSC Expansion SFM is a serum-free complete medium optimized for the maintenance and expansion of purified human MSCs. This product does not contain antibiotics. Catalog

More information

Supplementary Appendix

Supplementary Appendix Supplementary Appendix This appendix has been provided by the authors to give readers additional information about their work. Supplement to: Mateos M-V, Hernández M-T, Giraldo P, et al. Lenalidomide plus

More information

Use of an Automated Hematology Analyzer and Flow Cytometry to Assess Bone Marrow Cellularity and Differential Cell Count

Use of an Automated Hematology Analyzer and Flow Cytometry to Assess Bone Marrow Cellularity and Differential Cell Count Annals of Clinical & Laboratory Science, vol. 34, no. 3, 2004 307 Use of an Automated Hematology Analyzer and Flow Cytometry to Assess Bone Marrow Cellularity and Differential Cell Count Myungshin Kim,

More information

Philadelphia College of Osteopathic Medicine Annual Progress Report: 2010 Formula Grant

Philadelphia College of Osteopathic Medicine Annual Progress Report: 2010 Formula Grant Philadelphia College of Osteopathic Medicine Annual Progress Report: 2010 Formula Grant Reporting Period July 1, 2011 June 30, 2012 Formula Grant Overview The Philadelphia College of Osteopathic Medicine

More information

Diagnostic accuracy of monoclonal antibody based serum immunoglobulin free light chain immunoassays in myeloma cast nephropathy

Diagnostic accuracy of monoclonal antibody based serum immunoglobulin free light chain immunoassays in myeloma cast nephropathy Hutchison et al. BMC Clinical Pathology 2012, 12:12 TECHNICAL ADVANCE Open Access Diagnostic accuracy of monoclonal antibody based serum immunoglobulin free light chain immunoassays in myeloma cast nephropathy

More information

Laboratory Accreditation Test Validation: A Brave New World for Anatomic Pathology

Laboratory Accreditation Test Validation: A Brave New World for Anatomic Pathology Laboratory Accreditation Test Validation: A Brave New World for Anatomic Pathology Francis E. Sharkey, MD, FCAP University of Texas Health Science Center, San Antonio, TX Richard W. Brown, MD, FCAP Memorial

More information

HIGH SCHOOL STUDENT SCIENCE WEEK. St. Paul s Hospital Vancouver, BC

HIGH SCHOOL STUDENT SCIENCE WEEK. St. Paul s Hospital Vancouver, BC HIGH SCHOOL STUDENT SCIENCE WEEK St. Paul s Hospital Vancouver, BC Sponsors 2 AGENDA Location: UBC James Hogg Research Centre (JHRC), St. Paul s Hospital, Room 166 Burrard Building, 1081 Burrard Street,

More information

Multiple Myeloma: Diagnosis And Treatment READ ONLINE

Multiple Myeloma: Diagnosis And Treatment READ ONLINE Multiple Myeloma: Diagnosis And Treatment READ ONLINE If you are searching for a book Multiple Myeloma: Diagnosis and Treatment in pdf form, in that case you come on to the correct website. We presented

More information

Online Supplement ALVEOLAR CELL SENESCENCE IN PATIENTS WITH PULMONARY EMPHYSEMA. Takao Tsuji, Kazutetsu Aoshiba, and Atsushi Nagai

Online Supplement ALVEOLAR CELL SENESCENCE IN PATIENTS WITH PULMONARY EMPHYSEMA. Takao Tsuji, Kazutetsu Aoshiba, and Atsushi Nagai Online Supplement ALVEOLAR CELL SENESCENCE IN PATIENTS WITH PULMONARY EMPHYSEMA Takao Tsuji, Kazutetsu Aoshiba, and Atsushi Nagai MATERIALS AND METHODS Immunohistochemistry Deparaffinized tissue sections

More information

2013 Continuing Compliance Master Series Checklist Updates for Anatomic Pathology. Gerald A. Hoeltge, MD, FCAP July 17,

2013 Continuing Compliance Master Series Checklist Updates for Anatomic Pathology. Gerald A. Hoeltge, MD, FCAP July 17, 2013 Continuing Compliance Master Series Checklist Updates for Anatomic Pathology Gerald A. Hoeltge, MD, FCAP July 17, 2013 www.cap.org Today s Presenter Gerald A. Hoeltge, MD FCAP Chair, Checklists Committee

More information

ADAPTIVE BIOTECHNOLOGIES DIAGNOSTIC PORTAL: ACCOUNT LOGIN

ADAPTIVE BIOTECHNOLOGIES DIAGNOSTIC PORTAL: ACCOUNT LOGIN ADAPTIVE BIOTECHNOLOGIES DIAGNOSTIC PORTAL: ACCOUNT LOGIN 1. Create an account. To set up your account for our online order entry and reporting system, please go to: https://diagnostics.adaptivebiotech.com/account/login.

More information

Management of Multiple Myeloma: The Changing Paradigm

Management of Multiple Myeloma: The Changing Paradigm Management of Multiple Myeloma: The Changing Paradigm High-Dose Chemotherapy and Stem Cell Transplantation in the Era of Novel Therapies Larry Anderson, MD, PhD Multiple Myeloma and Stem Cell Transplant

More information

GenASIs TM Cytogenetics Suite

GenASIs TM Cytogenetics Suite GenASIs TM Cytogenetics Suite FDA 510(k) cleared for the following GenASIs applications: ALK, BandView, FISHView, UroVysion, CEP XY & HER2/neu FISH per the description found on the back page of this booklet.

More information

Ariol. Clinical IHC and FISH Breast Marker Analysis Quality. Efficiency. Confidence.

Ariol. Clinical IHC and FISH Breast Marker Analysis Quality. Efficiency. Confidence. Ariol Clinical IHC and FISH Breast Marker Analysis Quality. Efficiency. Confidence. 3 Behind every breast slide in your laboratory is a woman waiting for life changing answers With over 1.25 million women

More information

chronic leukemia lymphoma myeloma differentiated 14 September 1999 Transformed Pre- Ig Surface Surface Secreted B- ALL Macroglobulinemia Myeloma

chronic leukemia lymphoma myeloma differentiated 14 September 1999 Transformed Pre- Ig Surface Surface Secreted B- ALL Macroglobulinemia Myeloma Disease Usual phenotype acute leukemia precursor chronic leukemia lymphoma myeloma differentiated Pre- B-cell B-cell Transformed B-cell Plasma cell Ig Surface Surface Secreted Major malignant counterpart

More information

General Comments. Misinformation in Immunohistochemistry. Common Misinformation s in Immunohistochemistry 4/13/2017

General Comments. Misinformation in Immunohistochemistry. Common Misinformation s in Immunohistochemistry 4/13/2017 Common Misinformation s in Immunohistochemistry Tri State Meeting May 3, 2017 Steven Westra Reagent Product Specialist Leica Biosystems Misinformation in Immunohistochemistry Flood of New Markers Diagnostic

More information

Product Datasheet. CD31/PECAM-1 Antibody (C31.7) NBP mg. Unit Size: 0.1 mg. Store at 4C. Publications: 1

Product Datasheet. CD31/PECAM-1 Antibody (C31.7) NBP mg. Unit Size: 0.1 mg. Store at 4C. Publications: 1 Product Datasheet CD31/PECAM-1 Antibody (C31.7) NBP2-15188-0.1mg Unit Size: 0.1 mg Store at 4C. Publications: 1 Protocols, Publications, Related Products, Reviews, Research Tools and Images at: www.novusbio.com/nbp2-15188

More information

Schedule of Accreditation issued by United Kingdom Accreditation Service 2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK

Schedule of Accreditation issued by United Kingdom Accreditation Service 2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK Schedule of ccreditation United Kingdom ccreditation Service 2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK HSL (nalytics) LLP ccredited to Department of Parasitology HSL nalytics (LLP)

More information

Principles And Procedures

Principles And Procedures Product Identification Cat. No. Description 44674 Lambda Light Chain 0,1 M (Lamb14) 44675 Lambda Light Chain 1 M (Lamb14) 44326 Lambda Light Chain RTU M (Lamb14) Symbol Definitions P C A E S DIL DOC# DIS

More information

Carl Zeiss MicroImaging AIS. Digital Pathology The Future. Andrew Lesniak Director, Product Management

Carl Zeiss MicroImaging AIS. Digital Pathology The Future. Andrew Lesniak Director, Product Management Carl Zeiss MicroImaging AIS Digital Pathology The Future Andrew Lesniak Director, Product Management Defined Industry Needs Computer Aided Imaging and Analysis will play a key role in the increase of Diagnostics

More information

The Nuclear Area Factor (NAF): a measure for cell apoptosis using microscopy and image analysis

The Nuclear Area Factor (NAF): a measure for cell apoptosis using microscopy and image analysis The Nuclear Area Factor (NAF): a measure for cell apoptosis using microscopy and image analysis Mark A. DeCoster Department of Biomedical Engineering and Institute for Micromanufacturing, Louisiana Tech

More information

Reduction of the Platelet Review Rate Using the Two-Dimensional Platelet Method

Reduction of the Platelet Review Rate Using the Two-Dimensional Platelet Method Coagulation and Transfusion Medicine / REDUCTION OF THE PLTELET REVIEW RTE Reduction of the Platelet Review Rate Using the Two-Dimensional Platelet Method Deanne H. Chapman, MT(SCP)SH, 1 Jonn Hardin, MT,

More information

ISCT Telegraft Column: Mesenchymal Stromal Cell (MSC) Product Characterization and Potency Assay Development

ISCT Telegraft Column: Mesenchymal Stromal Cell (MSC) Product Characterization and Potency Assay Development ISCT Telegraft Column: Mesenchymal Stromal Cell (MSC) Product Characterization and Potency Assay Development University of Wisconsin-Madison, Production Assistance for Cellular Therapies (PACT) Over the

More information

Appendix B. The Curriculum in Cytotechnology for Entry-level Competencies

Appendix B. The Curriculum in Cytotechnology for Entry-level Competencies Preface Information: Appendix B The Curriculum in Cytotechnology for Entry-level Competencies This Curriculum in Cytotechnology was developed by the CPRC with input from cytopathology professionals to

More information

The clinical utility of IPF in thrombocytopenia

The clinical utility of IPF in thrombocytopenia The clinical utility of IPF in thrombocytopenia Platelets platelets Platelets are the smallest blood cells which are released by cytoplasmic blebbing of megakaryocytes with an average size of 2um. Normal

More information

Diagnosis and Follow-up of Multiple Myeloma and Related Disorders: The role of the laboratory

Diagnosis and Follow-up of Multiple Myeloma and Related Disorders: The role of the laboratory Diagnosis and Follow-up of Multiple Myeloma and Related Disorders: The role of the laboratory Anne L Sherwood, PhD Director of Scientific Affairs The Binding Site, Inc. Learning Objectives Compare traditional

More information

Billing Contact: Phone: Type of Research: NIH Funded Industry Funded Department Funded Study Name: CTRC Protocol: Start Date: End Date:

Billing Contact: Phone:   Type of Research: NIH Funded Industry Funded Department Funded Study Name: CTRC Protocol: Start Date: End Date: Please submit this application to CPRS@mednet.ucla.edu prior to beginning your research protocol. Please allow up to 2-3 weeks for the processing and approval of this application. All UCLA studies using

More information

Rapid Method for Permanent Slide Preparation of Colonies in Soft Agar Cultures

Rapid Method for Permanent Slide Preparation of Colonies in Soft Agar Cultures International Journal of Cell Cloning 4: 368-374 (1986) Rapid Method for Permanent Slide Preparation of Colonies in Soft Agar Cultures Jazbieh Moeui, Francis Ali-Osman, Martin J. Murphy, Jr. Hipple Caqcer

More information

Immunoglobulin / free light chain ratio

Immunoglobulin / free light chain ratio Immunoglobulin / free light chain ratio 1 1 2 Kiyotaka FUJITA Katsunori TAKAHASHI Ikunosuke SAKURABAYASHI FLC IgG, IgA, IgM, IgD, IgE 5 1 1 H 1 L H,,,, L 2 monoclonal immunoglobulinemia : M L L H 40 H

More information

Data Mining for Genomic- Phenomic Correlations

Data Mining for Genomic- Phenomic Correlations Data Mining for Genomic- Phenomic Correlations Joyce C. Niland, Ph.D. Associate Director & Chair, Information Sciences Rebecca Nelson, Ph.D. Lead, Data Mining Section City of Hope National Medical Center

More information

ASSESSMENT OF CLINICAL FLOW CYTOMETRY LABORATORY PRACTICE. First Edition Australasian Cytometry Society Laboratory Assessment Document

ASSESSMENT OF CLINICAL FLOW CYTOMETRY LABORATORY PRACTICE. First Edition Australasian Cytometry Society Laboratory Assessment Document ASSESSMENT OF CLINICAL FLOW CYTOMETRY LABORATORY PRACTICE First Edition 2018 Australasian Cytometry Society Laboratory Assessment Document Paper-based publications This work is copyright. You may reproduce

More information

Immunological Techniques in Research and Clinical Medicine. Philip L. Cohen, M.D. Chief of Rheumatology, LKSOM 10 March 2016

Immunological Techniques in Research and Clinical Medicine. Philip L. Cohen, M.D. Chief of Rheumatology, LKSOM 10 March 2016 Immunological Techniques in Research and Clinical Medicine Philip L. Cohen, M.D. Chief of Rheumatology, LKSOM 10 March 2016 Antibodies Remarkable Tools for Research and Diagnosis You can make an antibody

More information

Restrooms Cell phones on silent/vibrate. Refreshments. Patient resource materials

Restrooms Cell phones on silent/vibrate. Refreshments. Patient resource materials Restrooms Cell phones on silent/vibrate Refreshments Patient resource materials This presentation should not replace discussions with your healthcare provider, but seeks to provide information and resources

More information

TELE-HEMATOLOGY: CRITICAL DETERMINANTS FOR SUCCESSFUL IMPLEMENTATION

TELE-HEMATOLOGY: CRITICAL DETERMINANTS FOR SUCCESSFUL IMPLEMENTATION Blood First Edition From Paper, www.bloodjournal.org prepublished by online guest on September July 4, 2018. 11, For 2003; personal DOI use 10.1182/blood-2003-05-1615 only. TELE-HEMATOLOGY: CRITICAL DETERMINANTS

More information

GenomeMe. GeneAbTM Her2/Neu. Clone: IHC002 Source: Mouse Monoclonal Positive Control: Breast Carcinoma

GenomeMe. GeneAbTM Her2/Neu. Clone: IHC002 Source: Mouse Monoclonal Positive Control: Breast Carcinoma GeneAbTM Her2/Neu Clone: IHC002 Source: Mouse Monoclonal Positive Control: Breast Carcinoma 1. Intended Use This antibody is intended for in vitro diagnostic (IVD) use. The Her2/Neu (IHC002) antibody is

More information

CHAP10-CPTcodes _final doc Revision Date: 1/1/2018

CHAP10-CPTcodes _final doc Revision Date: 1/1/2018 CHAP10-CPTcodes80000-89999_final10312017.doc Revision Date: 1/1/2018 CHAPTER X PATHOLOGY / LABORATORY SERVICES CPT CODES 80000-89999 FOR NATIONAL CORRECT CODING INITIATIVE POLICY MANUAL FOR MEDICARE SERVICES

More information

School of Allied Medical Sciences. Course Description Guide Associate in Medical Laboratory Sciences. Page 1 of 15

School of Allied Medical Sciences. Course Description Guide Associate in Medical Laboratory Sciences. Page 1 of 15 School of Allied Medical Sciences Course Description Guide Associate in Medical Laboratory Sciences Page 1 of 15 Program Name & Definition: Associate in Medical Laboratory Sciences Laboratory sciences

More information

M1741 Validating a Whole Slide Imaging System A Case Based Approach to the CAP Guidelines

M1741 Validating a Whole Slide Imaging System A Case Based Approach to the CAP Guidelines M1741 Validating a Whole Slide Imaging System A Case Based Approach to the CAP Guidelines Brent T. Tan, MD, PhD, FCAP Objectives Design a validation study for a whole slide imaging system that meets CAP

More information

Pathology Facilities and Potential for Collaboration. The University of Western Australia

Pathology Facilities and Potential for Collaboration. The University of Western Australia Pathology Facilities and Potential for Collaboration UWA Pathology and Laboratory Medicine Pathology Research Themes Experimental pathology Infection and Immunity Translational pathology Cores Core Pathology

More information

WHITE PAPER FACTORS TO CONSIDER WHEN OUTSOURCING BIOREPOSITORY SERVICES

WHITE PAPER FACTORS TO CONSIDER WHEN OUTSOURCING BIOREPOSITORY SERVICES WHITE PAPER FACTORS TO CONSIDER WHEN OUTSOURCING BIOREPOSITORY SERVICES ppdi.com May 2012 EXECUTIVE SUMMARY Many pharmaceutical/biotechnology companies, government agencies and academic institutions concerned

More information

Significance of Abnormal Protein Bands in Patients with Multiple Myeloma following Autologous Stem Cell Transplantation

Significance of Abnormal Protein Bands in Patients with Multiple Myeloma following Autologous Stem Cell Transplantation Original Article Significance of Abnormal Protein Bands in Patients with Multiple Myeloma following Autologous Stem Cell Transplantation Sara L. Hall, 1 Jill Tate, 2 Devinder Gill, 1,3 *Peter Mollee 1,3

More information

Supplementary Figure 1. Characterization of the POP2 transcriptional and post-transcriptional regulatory elements. (A) POP2 nucleotide sequence

Supplementary Figure 1. Characterization of the POP2 transcriptional and post-transcriptional regulatory elements. (A) POP2 nucleotide sequence 1 5 6 7 8 9 10 11 1 1 1 Supplementary Figure 1. Characterization of the POP transcriptional and post-transcriptional regulatory elements. (A) POP nucleotide sequence depicting the consensus sequence for

More information

Dr Karen Whale and Tony Van Galen. Anatomical Pathology Royal Hobart Hospital

Dr Karen Whale and Tony Van Galen. Anatomical Pathology Royal Hobart Hospital Dr Karen Whale and Tony Van Galen Anatomical Pathology Royal Hobart Hospital 821 in Australia in 2016 266 in Victorian hospitals Royal Hobart Hospital State referral lab for renal biopsies 49 transplant

More information

background digitalization

background digitalization FRAUNHOFER Institute For integrated circuits IIS Microscopy SOFTWARE AND SYSTEMS FOR HISTOLOGY 1 Background Examination and assessment of tissue samples by the pathologist represent an essential element

More information